Kotak Healthcare Fund Direct-idcw
Latest AUM
₹ 442.3 Cr.
NAV as on 29 may, 2026
₹ 15.58
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 29 may, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 14.44% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 14.44% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.36% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.36% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.91% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.53% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.98% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.05% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.86% |
Debt & Credit Risk Analysis
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 8.47% | NA | 6.12% |
| 6 Months | 10.18% | NA | 12.92% |
| 9 Months | 12.52% | NA | 4.47% |
| 1 Year | 16.21% | 16.21% | 6.04% |
| 2 Years | 38.89% | 17.85% | 24.93% |
Kotak Healthcare Fund Direct-idcw is one Equity mutual fund offered by Kotak Mahindra Mutual Fund. Launched on 11 Dec 2023, the fund aims Long term capital growth. Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors. It manages assets worth ₹442.3 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.74%.
Dhananjay Tikariha has experience Prior to joining Kotak Mahindra Mutual Fund, he has worked with IDFC First Bank
Shibani Sircar Kurian has experience Prior to joining Kotak AMC, she was working with Dawnay Day AV India Advisors Pvt Ltd and UTI AMC.
Abhishek Bisen has experience Prior to joining Kotak AMC, he was working with Securities Trading Corporation Of India Ltd where he was looking at Sales & Trading of Fixed Income Products apart from doing Portfolio Advisory. His earlier assignments also include 2 years of merchant banking experience with a leading merchant banking firm.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Kotak Mahindra Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Kotak Healthcare Fund Direct-growth | 442.3 | +5.51% | +8.47% | +10.18% | +16.21% | — | — |
| Kotak Healthcare Fund Regular-growth | 442.3 | +5.37% | +8.02% | +9.31% | +14.35% | — | — |
| Kotak Healthcare Fund Regular-idcw | 442.3 | +5.37% | +8.02% | +9.31% | +14.35% | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +4.56% | +6.46% | +5.11% | +9.86% | +24.70% | +15.48% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.65% | +6.73% | +5.64% | +10.98% | +26.01% | +16.71% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹530.58 | +26.01% | +16.71% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹368.63 | +26.01% | +16.71% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹44.93 | +27.68% | +16.50% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹27.14 | +27.68% | +16.50% | — |
| Dsp Healthcare Fund Direct-growth | ₹45.57 | +24.25% | +15.96% | — |
| Dsp Healthcare Fund Direct-idcw | ₹26.35 | +24.25% | +15.96% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹47.19 | +26.14% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹28.42 | +26.14% | +15.83% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | ₹41.41 | +26.62% | +15.49% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | ₹24.16 | +26.62% | +15.49% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 29 May 2026 | ₹15.58 |
| 27 May 2026 | ₹15.74 |
| 25 May 2026 | ₹15.68 |
| 22 May 2026 | ₹15.62 |
| 21 May 2026 | ₹15.80 |
| 20 May 2026 | ₹15.73 |
| 19 May 2026 | ₹15.69 |
| 18 May 2026 | ₹15.56 |
| 15 May 2026 | ₹15.47 |
| 14 May 2026 | ₹15.54 |
| 13 May 2026 | ₹15.27 |
| 12 May 2026 | ₹15.18 |
| 11 May 2026 | ₹15.50 |
| 08 May 2026 | ₹15.32 |
| 07 May 2026 | ₹15.22 |
| 06 May 2026 | ₹15.19 |
| 05 May 2026 | ₹14.93 |
| 04 May 2026 | ₹14.93 |
| 30 Apr 2026 | ₹14.64 |
| 29 Apr 2026 | ₹14.65 |
| 28 Apr 2026 | ₹14.55 |
| 27 Apr 2026 | ₹14.59 |
| 24 Apr 2026 | ₹14.24 |
| 23 Apr 2026 | ₹14.40 |
| 22 Apr 2026 | ₹14.27 |
| 21 Apr 2026 | ₹14.20 |
| 20 Apr 2026 | ₹14.16 |
| 17 Apr 2026 | ₹14.16 |
| 16 Apr 2026 | ₹14.06 |
| 15 Apr 2026 | ₹14.07 |
Portfolio Updated on: 30 May, 2026
Fund Growth & Size Analysis
Compare Mutual funds
Kotak Healthcare Fund Direct-idcw Returns Comparison
Compare Kotak Healthcare Fund Direct-idcw with any MF,
EYF, stock or index
No funds found for your search.
